Invention Grant
- Patent Title: Thermodynamically stable crystal modification of 2-methyl-N-(5-methyl-1, 3, 4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide
-
Application No.: US15774200Application Date: 2016-11-04
-
Publication No.: US10336716B2Publication Date: 2019-07-02
- Inventor: Arnim Köhn , Christopher Hugh Rosinger , Christian Waldraff , Britta Olenik , Birgit Keil , Benedikt Mehl
- Applicant: Bayer CropScience Aktiengesellschaft
- Applicant Address: DE Monheim am Rhein
- Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
- Current Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
- Current Assignee Address: DE Monheim am Rhein
- Agency: Mcbee Moore Woodward & Vanik IP, LLC
- Priority: EP15193615 20151109
- International Application: PCT/EP2016/076620 WO 20161104
- International Announcement: WO2017/080912 WO 20170518
- Main IPC: A01N25/12
- IPC: A01N25/12 ; A01N43/82 ; C07D271/113
Abstract:
A thermodynamically stable crystal modification of 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide is described. This thermodynamically stable crystal modification has particular advantages in the stability of suspension formulations.
Public/Granted literature
Information query
